Fundraising FoxRNA NanoBiotics
1 known investors
Find your way into RNA NanoBiotics
Sign up to see every warm intro you have to RNA NanoBiotics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the RNA NanoBiotics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
RNA NanoBiotics develops programmable RNA nanostructures that deliver multiple therapeutic payloads with defined stoichiometry and staggered intracellular release for difficult-to-treat cancers. Its lead program targets EpCAM-positive metastatic colorectal cancer by delivering the chemotherapeutic SN38, with planned expansion to multi-payload combinations across additional oncology indications.
Founders & leadership
PG
Peixuan GuoChairman, Scientific Advisory Board
Investors · 1
Frequently asked questions
- What does RNA NanoBiotics do?
- RNA NanoBiotics develops programmable RNA nanostructures that deliver multiple therapeutic payloads with defined stoichiometry and staggered intracellular release for difficult-to-treat cancers. Its lead program targets EpCAM-positive metastatic colorectal cancer by delivering the chemotherapeutic SN38, with planned expansion to multi-payload combinations across additional oncology indications.
- Who are RNA NanoBiotics's investors?
- RNA NanoBiotics's investors include Symbiotic Ventures.